NICE recommends GLP-1 agonists for weight management in specific circumstances: for adults with at least one weight-related comorbidity and a BMI of 35 kg/m or above (or 32.5 kg/m or above for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds)
Quality & Sourcing Standards PSPeptides sources raw material for CJC No DAC Ipamorelin Spray from US-based manufacturing partners and requires independent lab verification before any batch is released for sale
Naggar I, Nakase K, Lazar J, Salciccioli L, Selesnick I, Stewart M
Can the Site Change Your Side Effects
Use a medication diary or tracking system
Talk to your provider to see if a GLP-1 treatment is right for you